Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Sun pharma

    Tag: sun pharma

    You Searched For "Sun pharma"
    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

    Sun Pharma signs licensing pact with AstraZeneca to introduce Novel Oncology products in China

    Medical Dialogues Bureau6 Nov 2019 1:26 PM IST
    Mumbai-Indian drugmaker giant Sun Pharma announced today about entering into an agreement with AstraZeneca to enter the Chinese market with novel...
    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Sun Pharma Advanced Research Company Q2 loss widens to Rs 63 cr

    Medical Dialogues Bureau5 Nov 2019 12:55 PM IST
    New Delhi: Sun Pharma Advanced Research Company (SPARC) on Monday reported a net loss of Rs 63.16 crore for the quarter ended September 30 of the...
    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    FIRST: Sun Pharma unveils dry-eye treatment drug CEQUA in US

    Farhat Nasim14 Oct 2019 1:13 PM IST
    New Delhi: Through a release, drug major, Sun Pharmaceutical Industries Ltd. (Sun Pharma) today announced that one of its wholly-owned subsidiaries...
    Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis

    Sun Pharma ILUMYA phase 3 trial shows significant skin clearance in people with Plaque Psoriasis

    Farhat Nasim11 Oct 2019 9:30 AM IST
    New Delhi: Sun Pharmaceutical Industries Ltd. recently announced that one of its wholly-owned subsidiaries presented long-term follow-up data from...
    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA

    SPARC neonatal seizures drug Phenobarbital gets Orphan Drug Designation from USFDA

    Farhat Nasim5 Oct 2019 12:00 PM IST
    Orphan Drug Designation will grant seven years of US market exclusivity upon approval of Phenobarbital for the treatment of patients with neonatal...
    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

    CDSCO warns against Cancer Causing Impurities in anti-acidity drug Ranitidine, writes to state drug controllers

    Farhat Nasim25 Sept 2019 1:19 PM IST
    New Delhi: To ensure patient safety, the country's apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) has ordered an...
    Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI

    Sun Pharma Revital H Woman ads misleading, inadequately substantiated: ASCI

    Medical Dialogues Bureau4 Sept 2019 5:18 PM IST
    New Delhi: Country's largest drugmaker, Sun Pharmaceuticals Ltd, (Sun Pharma) has been pulled up by the Advertising Standards Council of India (ASCI)...
    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Lupin gets USFDA approval for generic version of Westcort cream to treat skin conditions

    Farhat Nasim18 Aug 2019 9:46 AM IST
    Hydrocortisone Valerate cream is a generic version of Sun Pharmaceutical Industries Ltd's Westcort cream in the same strength, Lupin added.New Delhi:...
    NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details

    NPPA fixes retail price of 10 combo drugs including Metformin, Rosuvastatin; Details

    Farhat Nasim16 Aug 2019 4:01 PM IST
    New Delhi: Through a recent notification, the apex drug price regulatory agency, the National Pharmaceutical Pricing Authority (NPPA) has fixed the...
    Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter

    Sun Pharma records Total Revenue of Rs 8374.36 crore for June quarter

    Medical Dialogues Bureau16 Aug 2019 9:30 AM IST
    Mumbai: India's largest drugmaker Sun Pharmaceutical Industries Ltd. (Sun Pharma) recently reported a consolidated net profit of Rs 1,387.48 crore...
    Sun Pharma sudden closure of Vadodara RnD units leaves around 85 employees in lurch

    Sun Pharma sudden closure of Vadodara RnD units leaves around 85 employees in lurch

    Farhat Nasim3 Aug 2019 3:26 PM IST
    Mumbai: In a move that will axe job of around 85 employees (as pegged my market sources), Dilip Shanghvi led Sun Pharmaceuticals Ltd. (Sun Pharma) has...
    Sun Pharma to ramp up global speciality business; eyes "low-to-mid teens" growth in revenues for FY20

    Sun Pharma to ramp up global speciality business; eyes "low-to-mid teens" growth in revenues for FY20

    Medical Dialogues Bureau1 Aug 2019 10:00 AM IST
    The company is targeting key ailments like psoriasis to gradually ramp up its global speciality business, Dilip Shanghvi said adding that Sun Pharma...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok